CIK 0001802768
- Large accelerated filer
Royalty Pharma plc
Sign in to watch- Ticker
- RPRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +1 212-883-0200
- Business address
- 110 EAST 59TH STREET, NEW YORK, NY, 10022
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,573,345
- in 6 filings, $32.6M under 10b5-1 plans
Net −$32,573,345. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-30 | Legorreta Pablo G. CEO, Chairman of the Board | Gift | +292,190.49 | 292,190.49 | ||
| 2022-12-30 | Fernandez Henry A Director | Grant or award | +943 | $39.76 | $37K | 27,987 |
| 2022-12-30 | Bassler Bonnie L Director | Grant or award | +943 | $39.76 | $37K | 33,781 |
| 2022-12-09 | RIGGS RORY B Director | Sale | −19,990 | $42.07 | $841K | 136,722 |
| 2022-12-05 | Giuliani Mario Germano Director | Sale | −84,302 | $43.15 | $3.6M | 7,795,072 |
| 2022-12-02 | Giuliani Mario Germano Director | Sale | −197,766 | $43.98 | $8.7M | 7,879,374 |
| 2022-12-01 | Giuliani Mario Germano Director | Sale | −165,000 | $44.11 | $7.3M | 22,225,000 |
| 2022-11-22 | Lloyd George W. EVP, Investments & CLO | Sale | −14,469 | $43.19 | $625K | 130,000 |
| 2022-11-22 | Lloyd George W. EVP, Investments & CLO | Sale | −1,900 | $43.14 | $82K | 350,000 |
| 2022-11-21 | Lloyd George W. EVP, Investments & CLO | Sale | −20,531 | $43.11 | $885K | 144,469 |
| 2022-11-21 | Lloyd George W. EVP, Investments & CLO | Sale | −3,100 | $43.11 | $134K | 351,900 |
| 2022-11-17 | RIGGS RORY B Director | Sale | −120,000 | $42.33 | $5.1M | 156,712 |
| 2022-11-10 | Lloyd George W. EVP, Investments & CLO | Sale | −25,000 | $43.85 | $1.1M | 165,000 |
| 2022-11-10 | Lloyd George W. EVP, Investments & CLO | Sale | −25,000 | $43.85 | $1.1M | 355,000 |
| 2022-11-08 | Coyne Terrance P. EVP & CFO | Sale | −24,500 | $43.47 | $1.1M | 940,000 |
| 2022-11-02 | Coyne Terrance P. EVP & CFO | Sale | −5,500 | $43.06 | $237K | 964,500 |
| 2022-09-30 | Bassler Bonnie L Director | Grant or award | +913 | $41.06 | $37K | 32,838 |
| 2022-09-30 | Fernandez Henry A Director | Grant or award | +913 | $41.06 | $37K | 27,044 |
| 2022-09-28 | Reddoch James F. EVP & Chief Scientific Officer | Sale | −100,000 | $41.23 | $4.1M | 820,800 |
| 2022-09-28 | Giuliani Mario Germano Director | Sale | −32,593 | $41.05 | $1.3M | 8,077,140 |
Page 14 of 16 · 315 trades